Monthly Archives: August 2020

Johnson & Johnson : TRITON Phase 3b Study Results Presented at the European Society of Cardiology Congress – Marketscreener.com

Posted: Published on August 30th, 2020

While the primary endpoint was not met, exploratory analysis suggests a signal of reduced risk of disease progression of initial triple oral combination therapy vs initial double oral therapy for Pulmonary Arterial Hypertension (PAH) patients Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson, today announced results from the Phase 3b TRITON trial, the first randomised controlled study evaluating the efficacy and safety of initial triple oral combination therapy (UPTRAVI [selexipag], OPSUMIT [macitentan] and tadalafil) compared to initial double oral combination therapy (placebo, macitentan and tadalafil) in newly diagnosed, treatment-nave patients with pulmonary arterial hypertension (PAH). Study results were featured as an oral presentation as part of the digital European Society of Cardiology Congress held 29 August 1 September 2020. Continue reading

Posted in Clinical Cardiology | Comments Off on Johnson & Johnson : TRITON Phase 3b Study Results Presented at the European Society of Cardiology Congress – Marketscreener.com

Super-Responders in COAPT: Improving MR and QoL Is Key – TCTMD

Posted: Published on August 30th, 2020

Fewer than one in five patients enrolled in the COAPT trial of the MitraClip (Abbott) were super-responders to their assigned therapies, with more seen in the percutaneous intervention group than in the medical control group. But understanding at the outset which patients will benefit most from the clip remains murky. Writing in an early-online publication of the Journal of the American College of Cardiology, Paul A. Continue reading

Posted in Clinical Cardiology | Comments Off on Super-Responders in COAPT: Improving MR and QoL Is Key – TCTMD

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study – TCTMD

Posted: Published on August 30th, 2020

(UPDATED) Investigators who led a widely publicized cardiac magnetic resonance (CMR) study showing that COVID-19 may cause lingering cardiac damage have responded to questions raised on social media challenging their findings. Eike Nagel, MD, and Valentina Puntmann, MD, PhD (both University Hospital Frankfurt, Germany), issued a correction this week in JAMA Cardiology, stating they reviewed and reanalyzed their data after TCTMD alerted to them Twitter discussions about their work Continue reading

Posted in Clinical Cardiology | Comments Off on ‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study – TCTMD

Research Moz Releases New Report on the Multiple Sclerosis Treatment Market 2019-2025 – StartupNG

Posted: Published on August 30th, 2020

Multiple Sclerosis Treatment Market Scope of the Report: Factors and Multiple Sclerosis Treatment Market execution are analyzed using quantitative and qualitative approaches to give a consistent picture of current and future trends in the boom. The study also allows for a detailed market analysis focused primarily on geographic locations Continue reading

Posted in MS Treatment | Comments Off on Research Moz Releases New Report on the Multiple Sclerosis Treatment Market 2019-2025 – StartupNG

Jenn Sterger Rips Dan Snyder, NFL Over Treatment of Women: ‘Show Us That We Matter’ – CBS Sports Radio 910

Posted: Published on August 30th, 2020

After more allegations came out against the culture of the Washington Football Team, this time directly implicating owner Daniel Snyder, he was quick to respond and refute much of what had been said. Continue reading

Posted in MS Treatment | Comments Off on Jenn Sterger Rips Dan Snyder, NFL Over Treatment of Women: ‘Show Us That We Matter’ – CBS Sports Radio 910

American Heart Association and Barth Syndrome Foundation Partner to Address Rare Disease – PR Web

Posted: Published on August 29th, 2020

Barth Syndrome Foundation Logo BOSTON (PRWEB) August 24, 2020 Barth Syndrome Foundation (BSF) and American Heart Association (AHA) have announced a first-ever partnership to advance research studying cardiac complications associated with Barth syndrome, a rare, life-threatening, mitochondrial disease. Structured as a fellowship, the partnership aims to also address a severe shortage of early-career researchers by incentivizing a focus on a rare indication. This important collaboration between the AHA and BSF marks a strategic shift by BSF to broaden its impact by joining forces to accelerate progress through science and education Continue reading

Posted in Ventricular Remodeling | Comments Off on American Heart Association and Barth Syndrome Foundation Partner to Address Rare Disease – PR Web

Gene Therapy in Dogs Shows Progress for Krabbe Disease Treatment – Science Times

Posted: Published on August 29th, 2020

An effective gene therapy for Krabbe disease treatment done in dogs might lead to a potential approach for the same disease in human children, a new study suggests. A research team, led by the University of Pennsylvania, details an effective gene therapy procedure used in dogs to lasting effects, highlighting the potential for a similar approach to children. The methods and results of their studies are published in the latest Journal of Clinical Investigation (JCI). Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Gene Therapy in Dogs Shows Progress for Krabbe Disease Treatment – Science Times

Cerebral Palsy Market is Expected to Thrive at Impressive CAGR by 2026 & Top Key Players are Allergan Plc, Cell Cure Neurosciences, Ltd., Cellular…

Posted: Published on August 29th, 2020

Dataintelo offers a latest published report on Global Cerebral Palsy Market industry analysis and forecast 20192025 delivering key insights and providing a competitive advantage to clients through a detailed report. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Cerebral Palsy Market is Expected to Thrive at Impressive CAGR by 2026 & Top Key Players are Allergan Plc, Cell Cure Neurosciences, Ltd., Cellular…

A Very Special Inspiration: When Disabled TV Characters Existed Only to Teach Empathy – IndieWire

Posted: Published on August 29th, 2020

This is part of an ongoing series that looks at the history of disability issues in television. You can find part one in the series here. As a disabled writer, I will use both person-first and identity-first language interchangeably for purposes of brevity and clarity. Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on A Very Special Inspiration: When Disabled TV Characters Existed Only to Teach Empathy – IndieWire

FASD awareness month works to reduce the stigma of the most preventable disability – LacombeOnline.com

Posted: Published on August 29th, 2020

September is Fetal Alcohol Spectrum Disorder awareness month, and the people at the Central Alberta FASD Network want to get the word out there about how to avoid the most preventable known disability. While the symptoms can vary, less than 10% of people who have FASD display physical symptoms, which can make it tough to diagnose, and there is no cure or form of treatment besides support Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on FASD awareness month works to reduce the stigma of the most preventable disability – LacombeOnline.com